Reuters - Health Report

Click to View in Browser

Wednesday, September 13, 2017

Progress on global poverty and disease at risk, Gates says

LONDON, (Reuters) - Proposed United States budget cuts could put in jeopardy great progress in reducing global poverty and disease and lead to 5 million more deaths from AIDS alone, the philanthropist Bill Gates warned on Wednesday.

Novartis says biosimilar rituximab accepted for review by FDA

ZURICH (Reuters) - Novartis AG said on Tuesday its biosimilar rituximab to treat blood cancers and immunological diseases such as rheumatoid arthritis was accepted for review by the U.S. Food and Drug Administration (FDA).

Mylan says Allergan misusing tribal sovereignty in patent dispute

NEW YORK (Reuters) - Generic drugmaker Mylan NV alleged in a court filing that rival Allergan Plc is trying to take advantage of Native American sovereignty to shield its patent for the blockbuster dry-eye treatment Restasis.

Sage's seizure drug fails key trial, shares slump

(Reuters) - Sage Therapeutics Inc's shares tumbled 23 percent on Tuesday after its drug to treat a life-threatening seizure disorder failed to meet the main goal of a key trial, raising concerns about the future of the study.

Texas calls in U.S. Air Force to counter post-storm surge in mosquitoes

HOUSTON (Reuters) - Texas has launched aerial attacks on mosquitoes swarming coastal regions of the state and threatening to spread disease and hinder disaster recovery in the aftermath of Hurricane Harvey.

Key U.S. senators reach deal on funding children's health program

WASHINGTON (Reuters) - Leaders of the U.S. Senate Finance Committee said on Tuesday they reached an agreement to finance a federal insurance program for millions of lower-income children and pregnant women that was due to expire at the end of the month.

Tech entity has tribal patent deal similar to Allergan's

(Reuters) - The Native American tribe that agreed to hold patents for the drug company Allergan Plc in an attempt to shield them from U.S. administrative review is also doing so for a technology firm.

Clinigen boost unlicensed drugs business with Quantum takeover

LONDON (Reuters) - Britain's Clinigen Group on Wednesday agreed to buy Quantum Pharma for 150.3 million pounds ($200 million), bringing together two companies that specialize in the supply of unlicensed medicines to doctors and hospitals.

Moms most exposed to pesticides more likely to have preterm babies

(Reuters Health) - Women exposed to the highest quantities of agricultural pesticides in California’s San Joaquin Valley while pregnant were at heightened risk of giving birth prematurely and delivering low-weight infants, a new study found.

France eyes legalizing assisted reproduction for gay women in 2018

PARIS (Reuters) - The right of lesbian couples and single women to have access to assisted reproduction was "a matter of social justice" and will likely be legislated next year, a French government minister said on Tuesday.